Dianthus Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel treatments for complement-mediated autoimmune and inflammatory diseases. The company's lead program targets rare diseases where the complement system, a part of the immune system, causes tissue damage. Dianthus is advancing therapies designed to selectively inhibit specific components of the complement cascade. The company's pipeline addresses significant unmet medical needs in conditions with limited treatment options.